Tokyo, Aug. 7 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058712) titled 'Therapeutic Option for Nintedanib related diArrhea in patients with progressive fibrosing interstitial lung disease a multicenter Clinical triAl' on Aug. 6.

Study Type: Interventional

Study Design: Basic Design - Parallel Randomization - Randomized Blinding - Open -no one is blinded Control - Dose comparison

Primary Sponsor: Institute - Shinmatsudo central general Hospital

Condition: Condition - Patients with PF-ILD, excluding scleroderma Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - Validating the nintedanib dose reduction group versus MiyaBM addition group treating nintedanib-associated diarrhea in patients with PF-ILD, excluding scleroderma, in a randomized comparison using the diarrhea index. Basic objectives2 - Others

Intervention: Interventions/Control_1 - After onset of nintedanib-associated diarrhea, nintedanib dose was reduced (nintedanib 150 mg twice a day in the morning and evening is reduced to 100 mg twice a day). Interventions/Control_2 - After onset of nintedanib-associated diarrhea, MIYA BM (two MIYA BM tablets three times a day after breakfast, lunch and dinner) is added without reducing nintedanib dose.

Eligibility: Age-lower limit - 20 years-old

Gender - Male and Female Key inclusion criteria - Patients with PF-ILD, excluding scleroderma 20 to 80 years old at the time consent is obtained Any previous treatment is included Written informed consent is obtained Key exclusion criteria - Those who consume yogurt (including beverages) within 1 week prior to the start of nintedanib Those who already taking MIYA BM or Biofermin before starting nintedanib Patients allergic to digestive medications Those who are deemed by the attending physician to be ineligible for this study Target Size - 60

Recruitment Status: Recruitment status - Preinitiation Date of protocol fixation - 2025 Year 06 Month 02 Day Anticipated trial start date - 2025 Year 06 Month 30 Day Last follow-up date - 2030 Year 09 Month 30 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066249

Disclaimer: Curated by HT Syndication.